On May 27 and 28, Surfing the NASH Tsunami covered the 5th Global NASH Congress, which discussed a wide range of NAFLD-related topics. In this conversation, Louise Campbell interviews Julius Clinical Chief Scientific Officer Diederick (Rick) Grobbee about NAFLD screening in primary care practices as exemplified in Julius’s GRIP Program.

Most of this conversation centered around the GRIP Program, an effort to screen 10,000 metabolic disease patients in 10 European countries. The program has targeted screening 1,000 patients per country in primary care practices using VCTE as the initial screening tool. Rick and Louise review the scope and goals of the project. Along the way, their conversation also covers the need to find more patients for clinical trials and how Julius Clinical anticipates GRIP addressing this need. Other topics Louise and Rick cover include the value of a FibroScan or other scanning device in motivating patients as compared to blood tests and the need to create guidelines that make medical and economic sense in primary care practices